๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer

โœ Scribed by Daniel J. Haraf; Everett E. Vokes; Ralph R. Weichselbaum; William R. Panje

Book ID
115043892
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
711 KB
Volume
102
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Weekly 5-fluorouracil plus cisplatin for
Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer
โœ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5โ€fluorouracil (5โ€FU) and cisplatin has increased acute toxicities as well as survival. Onceโ€weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we

Concomitant radiochemotherapy in primary
Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C
โœ Hans Christiansen; Robert M. Hermann; Andrea Hille; Elisabeth Weiss; Mirko Nitsc ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 534 KB

## Abstract ## Background. The purpose of this study was to evaluate the efficacy and toxicity of radiotherapy and concomitant 5โ€fluorouracil (5โ€FU) and mitomycinโ€C infusion in inoperable head and neck cancer. ## Methods. Seventyโ€six patients (86% men, 14% women), mean age 57 years, with primary